Glenmark Pharmaceuticals Ltd
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 2,468.99 | 1,824.42 | 2,464.26 |
| Operating Expense | 2,041.30 | 2,648.45 | 1,990 |
| Net Profit | 282.07 | -739.19 | 330.23 |
| Net Profit Margin | 11.42% | -40.52% | 13.40% |
| Earning Per Share | 10 | -26.19 | 11.70 |
| EBIDTA | 363.23 | -727.03 | 473.50 |
| Effective Tax Rate | 0% | 8.52% | 14.80% |
Particulars
Dec 2025
Revenue2,468.99
Operating Expense2,041.30
Net Profit282.07
Net Profit Margin11.42
Earning Per Share10
EBIDTA363.23
Effective Tax Rate0
